Updates Full-Year Guidance
Results from Continuing Operations for first quarter 2024 versus last year:Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7%Diluted EPS:.
The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment
BURLINGTON, N.C., April 10, 2024 /PRNewswire/.
Fecal Dx antigen testing will soon detect the most common intestinal parasites earlier, uncovering more infections
WESTBROOK, Maine, Jan. 12, 2024 /PRNewswire/ IDEXX Laboratories, Inc. , a global.